Targeting Inflammation to Fight Cancer

Output

Wetenschappelijk artikel

  • R.M. Schiffelers, G Storm(2008): Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells Int J Pharm pp. 258 - 264
  • M Coimbra(2009): Targeted delivery of anti-inflammatory agents to tumors Curr Pharm Des
  • SA Kuijpers(2010): Liposomes targeting tumour stromal cells Mol Membr Biol.
  • M Coimbra(2010): Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. J Control Release
  • R.M. Schiffelers, MJ Coimbra(2011): Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. International Journal Pharmaceutics pp. 433 - 442
  • M. Coimbra, B. Isacchi, L. van Bloois, J.S. Torano, A. Ket, X. Wu, F. Broere, J.M. Metselaar, C.J.F. Rijcken, G. Storm, R. Bilia, R.M. Schiffelers(2011): Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. International Journal of Pharmaceutics pp. 433 - 42 ISSN: 0378-5173.
  • MJ Coimbra, R.M. Schiffelers(2012): Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines. Journal Controlled Release pp. 232 - 238
  • MJ Coimbra, R.M. Schiffelers(2012): Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles. Journal Controlled Release pp. 361 - 367

Kenmerken

Projectnummer

07947

Hoofdaanvrager

Prof. dr. R.M. Schiffelers

Verbonden aan

Universiteit Utrecht, Universitair Medisch Centrum Utrecht, Wilhelmina Kinderziekenhuis

Uitvoerders

Prof. dr. R.M. Schiffelers

Looptijd

01/10/2007 tot 14/11/2013

Budget

€ 405.600